Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:297-299
doi: 10.1161/CIRCULATIONAHA.106.675397
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Towler, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Towler, D. A.
Related Collections
Right arrow Remodeling
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Pathophysiology
Right arrow Gene expression
Right arrow Imaging
Right arrow Valvular heart disease
Right arrow Other Vascular biology

(Circulation. 2007;115:297-299.)
© 2007 American Heart Association, Inc.


Editorial

Imaging Aortic Matrix Metabolism

Mirabile Visu!

Dwight A. Towler, MD, PhD

From the Center for Cardiovascular Research, Washington University School of Medicine, Department of Internal Medicine, Bone and Mineral Diseases, St Louis, Mo.

Correspondence to Dwight A. Towler, MD, PhD, Internal Medicine–BMD, Washington University School of Medicine, Barnes-Jewish Hospital North Campus Box 8301, 660 South Euclid Ave, St Louis, MO 63110. E-mail dtowler@im.wustl.edu


Key Words: Editorials • aorta • atherosclerosis • calcium • imaging • inflammation • muscle, smooth


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Aortic calcification increasingly afflicts our aging and dysmetabolic population.1 In the past decade, multiple studies from preclinical and clinical investigators have identified that active osteogenic/chondrogenic mechanisms contribute to aortic calcium load.2 Cellular and matricrine signals control vascular calcium phosphate mineral deposition via processes resembling membranous and endochondral bone formation.2–4 Clinical consequences also have begun to emerge.2,4 Atherosclerotic calcification of the aortic arch portends ischemic cerebrovascular events in women, although mitral annulus calcification may be a better predictor.5 Medial artery calcification, a nonobstructive form of aortofemoral calcium accumulation, is a characteristic vascular pathology seen in patients with type II diabetes or chronic renal failure.3 Medial artery calcification not only is a predictor of cardiovascular mortality but also increases the risk for lower extremity amputation6; vascular stiffening perturbs normal aortofemoral Windkessel physiology, thus compromising distal tissue perfusion while increasing afterload, pulse pressure, and myocardial workload.3,4 Aortic valve calcium accumulation assessed by echocardiography is a strong predictor of disease progression in patients with initially asymptomatic aortic stenosis.7 In end-stage renal disease patients on dialysis, the presence of aortic valve calcification is a particularly ominous risk factor for cardiovascular mortality.8 All forms of aortic and aortic valve calcification are increased along the metabolic syndrome to type II diabetes continuum.1 The detailed analysis by Katz et al1 of the Multiethnic Study of Atherosclerosis cohort revealed stepwise increases in aortic valve calcification risk with accrual of metabolic syndrome risk factors.1 As highlighted by Bostrom,9 vascular mineralization not only promotes further epitaxial mineral deposition but also . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
CirculationHome page
E. Aikawa, M. Aikawa, P. Libby, J.-L. Figueiredo, G. Rusanescu, Y. Iwamoto, D. Fukuda, R. H. Kohler, G.-P. Shi, F. A. Jaffer, et al.
Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease
Circulation, April 7, 2009; 119(13): 1785 - 1794.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X. Yang, D. A. Fullerton, X. Su, L. Ao, J. C. Cleveland Jr, and X. Meng
Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2.
J. Am. Coll. Cardiol., February 10, 2009; 53(6): 491 - 500.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Aikawa, M. Nahrendorf, J.-L. Figueiredo, F. K. Swirski, T. Shtatland, R. H. Kohler, F. A. Jaffer, M. Aikawa, and R. Weissleder
Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo
Circulation, December 11, 2007; 116(24): 2841 - 2850.
[Abstract] [Full Text] [PDF]